• 1
    Bernardi M, Santini C, Trevisani F, Baraldini M, Logabue A, Gasbarrini G. Renal function impairment induced by change in posture in patients with cirrhosis and ascites. Gut 1985; 26: 629635.
  • 2
    Ring-Larsen H, Hesse B, Henriksen JH, Christensen NJ. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release. Hepatology 1982; 2: 304310.
  • 3
    Bernardi M, Trevisani F, Santini C, Zoli G, Baraldini M, Ligabue A, Gasbarrini G. Plasma, Norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology 1983; 3: 5664.
  • 4
    Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. BMJ 1986; 292: 13511353.
  • 5
    Wade CA, Claybaugh JR. Plasma renin activity, vasopressin concentration and urinary excretory responses to exercise in men. J Appl Physiol 1980; 49: 930936.
  • 6
    Olsen NV, Kanstrup IL, Richalet JP, Hansen JM, Plazen G, Galen FJ. Effects of acute hypoxia on renal and endocrine function at rest and during graded exercise in hydrated subjects. J Appl Physiol 1992; 73: 20362043.
  • 7
    Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J. Renal neurohormo-nal and vascular responses to dynamic exercise in humans. J Appl Physiol 1991; 70: 22792286.
  • 8
    Freund BJ, Shizuru EM, Hashiro GM, Claybaugh JR. Hormonal, electrolyte, and renal responses to exercise are intensity dependent. J Appl Physiol 1991; 70: 900906.
  • 9
    Saló J, Ginès A, Anibarro L, Jiménez W, Bataller R, Clària J, Ginès P, et al. Effect of upright posture and physical exercise on endogenous neurohor-monal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels. Hepatology 1995; 22: 479487.
  • 10
    Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, Gasbarrini G. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991; 12: 207216.
  • 11
    Mitchell JH. Cardiovascular control during exercise: central and reflex neural mechanisms. Am J Cardiol 1985; 55: 34D41D.
  • 12
    Rowell LB, O'Leary DS. Reflex control of the circulation during exercise: chemoreflexes and mechanoreflexes. J Appl Physiol 1990; 69: 407418.
  • 13
    Kachadorian WA, Johnson RE. Renal responses to various rates of exercise. J Appl Physiol 1970; 28: 748752.
  • 14
    Grimby G. Renal clearances during prolonged supine exercise at different loads. J Appl Physiol 1965; 20: 12941298.
  • 15
    Poortmans JR. Exercise and renal function. Sports Med 1984; 1: 125153.
  • 16
    Jette M, Sidney K, Blunchen G. Metabolic equivalents (METs) in exercise testing, exercise prescription and evaluation of functional capacity. Clin Cardiol 1990; 13: 553565.
  • 17
    Pérez-Ayuso RM, Arroyo V, Camps J, Rimola A, Gaya J, Costa J, Rivera F, et al. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int 1984; 26: 7280.
  • 18
    Asbert M, Jiménez W, Gaya J, Ginès P, Arroyo V, Rivera F, Rodés J. Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunore-active renin. J Hepatol 1992; 15: 179183.
  • 19
    Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó LL, Serra A, et al. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology 1988; 8: 636642.
  • 20
    Davies DF, Shock NN. The variability of measurement of inulin and dio-drast tests of kidney function. J Clin Invest 1950; 29: 491495.
  • 21
    Black DAK, Cameron JJ. Renal function. In: BrownSS, MitchellFL, YoungDS, eds. Chemical Diagnosis of Disease. New York: Elsevier, 1979: 453524.
  • 22
    Francis GS. Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease. Circulation 1987; 76 (suppl 6): 1117.
  • 23
    Hasking GJ, Esler MD, Jennings GL, Dewar E, Lambert G. Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation 1988; 78: 516521.
  • 24
    Flamm SD, Taki J, Moore R, Lewis SF, Keech F, Maltais F, Ahmad M, et al. Redistribution of regional and organ blood volume and effect on cardiac function in relation to upright exercise intensity in healthy human subjects. Circulation 1990; 81: 15501559.
  • 25
    Tanaka H, Shindo M, Gutkowska J, Kinoshita A, Urata H, Ikeda M, Ara-kawa K. Effect of acute exercise on plasma immunoreactive atrial natriuretic factor. Life Sci 1986; 39: 16851693.
  • 26
    Schmidt W, Brabant G, Kroger C, Strauch S, Hilgendorf A. Atrial natriuretic peptide during and after maximal and submaximal exercise under normoxic and hypoxic conditions. Eur J Appl Physiol 1990; 61: 398407.
  • 27
    Virvidakis C, Loukas A, Mayopoulou-Symvoulidou D, Mountokalakis T. Renal response to bicycle exercise in trained athletes: influence of exercise intensity. Int J Sports Med 1986; 7: 8688.
  • 28
    Agustí A, Roca J, Rodriguez-Roisin R, Mastai R, Wagner PD, Bosch J. Pulmonary Hemodynamics and gas exchange during exercise in liver cirrhosis. Am Rev Respir Dis 1989; 139: 485491.
  • 29
    DeLissio M, Goodyear LJ, Fuller S, Krawitt EL, Devlin JT. Effects of treadmill exercise on fuel metabolism in hepatic cirrhosis. J Appl Physiol 1991; 70: 210215.
  • 30
    Campillo B, Fouet P, Bonnet JC, Atlan G. Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. J Hepatol 1990; 10: 163167.
  • 31
    Kelbaek H, Rabol A, Brynjolf I, Eriksen J, Bonnevie O, Godtfredsen J, Munck O, et al. Haemodynamic response to exercise in patients with alcoholic liver cirrhosis. Clin Physiol 1987; 7: 3541.
  • 32
    Campillo B, Chapelain C, Bonnet JC, Frisdal E, Devanlay M, Bouissou P, Fouet P, et al. Hormonal and metabolic changes during exercise in cirrhotic patients. Metabolism 1990; 39: 1824.
  • 33
    Arroyo V, Ginès P, Rimola A, Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. Am J Med 1986; 81: 104122.
  • 34
    Clària J, Ros J, Jiménez W, Bosch M, Angeli P, Arroyo V, Rivera F, et al. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 1995; 22: 915920.
  • 35
    Ginès P, Arroyo V, Rodes J. Disorders of renal function in cirrhosis: patho-physiology and clinical aspects. In: ZakimD, BoyerJ, eds. Hepatology. A Textbook of Liver Disease. Philadelphia: Saunders, 1996: 650675.
  • 36
    Zambraski EJ, Dodelson R, Guidotti SM, Harnett CA. Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac. Med Sci Sports Exerc 1986; 18: 678684.
  • 37
    Koivisto VA, Jantunen M, Sane T, Helve E, Pelkonen R, Viinikla L, Ylikor-kala O. Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. Diabetes Care 1989; 12: 609614.
  • 38
    Nadler JL, Yamamoto JV. Diurnal variation and exercise induced changes of prostacyclin in man. Prostaglandins Leukot Med 1986; 22: 7178.
  • 39
    Zipser RD, Hoefs JC, Speckart PF, Zia PK, Horton R. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 1979; 48: 895900.
  • 40
    Boyer TD, Zia P, Reynolds TB. Effects of indomethacin and prostaglandin Al in renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1979; 77: 215222.
  • 41
    Arroyo V, Planas R, Gaya J, Deulofeu R, Rimola A, Pérez-Ayuso RM, Rivera F, et al. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983; 13: 271278.
  • 42
    Gilligan DM, Panza JA, Kilcoyne RN, Waclawiw MA, Casino PR, Quyyumi A. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1994; 90: 28532858.
  • 43
    Raij L. Nitric oxide and the kidney. Circulation 1993; 87 (suppl 5): 2639.
  • 44
    Ginès P, Arroyo V, Rodes J. Pharmacotherapy of ascites associated with cirrhosis. Drugs 1992; 43: 316332.